Cited by 6,471Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, Peter C.·1976·Science

Open this paper in CoChat — free account

Abstract

It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.

Integrity signals

Registry

Crossref · 10.1126/science.959840

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
Chromosomes and cancer
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 24

ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
Oksala, T., Chromosomes and Cancer: 239 (1974).
Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
RUBIN, H, SCIENCE 191: 241 (1976). · DOI
STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).

Sorted by citations

Items 401–500 of 1,016

An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs
Ruiz-Torres, V., Encinar, J. A., Herranz‐López, M., Pérez-Sánchez, A., Galiano, V., Barrajón‐Catalán, E., & Micol, V. (2017) · Molecules · doi:10.3390/molecules22071037 · Cited by 234
Clinical cancer genomic profiling
Chakravarty, D., & Solit, D. B. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00338-8 · Cited by 241
Expression of pituitary-tumour transforming gene in colorectal tumours
Heaney, A. P., Singson, R., McCabe, C. J., Nelson, V., Nakashima, M., & Melmed, S. K. (2000) · The Lancet · doi:10.1016/s0140-6736(99)10238-1 · Cited by 229
Analysis of the most representative tumour‐derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation.
Ory, K., Legros, Y., Auguin, C., & Soussi, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06656.x · Cited by 230
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma
Wu, C. X., Wang, X. Q., Chok, K., Man, K., Tsang, S. H. Y., Chan, A. C. Y., Wing, K., Xia, W. G., & Cheung, T. T. (2018) · Theranostics · doi:10.7150/thno.25487 · Cited by 228
Outgrowth of single oncogene-expressing cells from suppressive epithelial environments
Leung, C. T., & Brugge, J. S. (2012) · Nature · doi:10.1038/nature10826 · Cited by 233
Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes
Kon, S., Ishibashi, K., Katoh, H., Kitamoto, S., Shirai, T., Tanaka, S., Kajita, M., Ishikawa, S., Yamauchi, H., Yako, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3509 · Cited by 226
The influence of subclonal resistance mutations on targeted cancer therapy
Schmitt, M. W., Loeb, L. A., & Salk, J. J. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.175 · Cited by 234
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
Xiang, D., Shigdar, S. L., Qiao, G. G., Wang, T., Kouzani, A. Z., Zhou, S., Kong, L., Li, Y., Pu, C., & Duan, W. (2014) · Theranostics · doi:10.7150/thno.10202 · Cited by 223
Cancer stem cells: In the line of fire
Alison, M. R., Lin, W., Lim, S. M. L., & Nicholson, L. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.003 · Cited by 228
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
Smith, A., Mohamedali, A. M., Kulasekararaj, A. G., Lim, Z., Gäken, J. A., Lea, N. C., Przychodzen, B. P., Mian, S. A., Nasser, E. E., Shooter, C. C., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274704 · Cited by 236
Mismatch repair defects in human carcinogenesis
Eshleman, J. R., & Markowitz, S. D. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.supplement_1.1489 · Cited by 222
Antioxidants and multistage carcinogenesis in mouse skin
Perchellet, J., & Perchellet, E. M. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90124-x · Cited by 224
SIRT3 regulates progression and development of diseases of aging
McDonnell, E., Peterson, B. S., Bomze, H. M., & Hirschey, M. D. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.06.001 · Cited by 217
OncoNEM: inferring tumor evolution from single-cell sequencing data
Ross, E. M., & Markowetz, F. M. (2016) · Genome biology · doi:10.1186/s13059-016-0929-9 · Cited by 226
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
Shu, Y., Wu, X., Tong, X., Wang, X., Chang, Z., Mao, Y., Chen, X., Sun, J., Wang, Z., Hong, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00520-1 · Cited by 226
Towards Multidrug Adaptive Therapy
West, J., You, L., Zhang, J., Gatenby, R. A., Brown, J. S., Newton, P. K., & Anderson, A. R. A. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2669 · Cited by 226
The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b
Zhou, W., Ye, X., Xu, J., Cao, M., Fang, Z., Li, L., Guan, G.-H., Liu, Q., Qian, Y.-H., & Xie, D. (2017) · Science Signaling · doi:10.1126/scisignal.aak9557 · Cited by 224
Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage.
Malins, D. C., Polissar, N. L., & Gunselman, S. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2557 · Cited by 222
Reconstruction of clonal trees and tumor composition from multi-sample sequencing data
El-Kebir, M., Oesper, L., Acheson-Field, H., & Raphael, B. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv261 · Cited by 219
High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma
Mroz, E. A., Tward, A. D., Pickering, C. R., Myers, J. N., Ferris, R. L., & Rocco, J. W. (2013) · Cancer · doi:10.1002/cncr.28150 · Cited by 227
Radiation-induced genomic instability and its implications for radiation carcinogenesis
Huang, L., Snyder, A. R., & Morgan, W. F. (2003) · Oncogene · doi:10.1038/sj.onc.1206697 · Cited by 227
Cancers Exhibit a Mutator Phenotype: Clinical Implications
Loeb, L. A., Bielas, J. H., & Beckman, R. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5835 · Cited by 220
An evolutionary hybrid cellular automaton model of solid tumour growth
Gerlee, P., & Anderson, A. R. A. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.01.027 · Cited by 222
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
Bosse, K. R., & Maris, J. M. (2015) · Cancer · doi:10.1002/cncr.29706 · Cited by 222
Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing
Jiang, Y., Qiu, Y. L., Minn, A. J., & Zhang, N. R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522203113 · Cited by 216
The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome
Caswell, D. R., & Swanton, C. (2017) · BMC Medicine · doi:10.1186/s12916-017-0900-y · Cited by 225
Clonal genome evolution and rapid invasive spread of the marbled crayfish
Gutekunst, J., Andriantsoa, R., Falckenhayn, C., Hanna, K., Stein, W., Rasamy, J., & Lyko, F. (2018) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0467-9 · Cited by 228
Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine
Raphael, B. J., Dobson, J. R., Oesper, L., & Vandin, F. (2014) · Genome Medicine · doi:10.1186/gm524 · Cited by 226
Molecular biology of colorectal cancer
Gryfe, R., Bapat, B. V., Gallinger, S., Swallow, C. J., Redston, M. S., & Couture, J. (1997) · Current Problems in Cancer · doi:10.1016/s0147-0272(97)80003-7 · Cited by 224
Jumping Translocations of Chromosome 1q in Multiple Myeloma: Evidence for a Mechanism Involving Decondensation of Pericentromeric Heterochromatin
Sawyer, J. R., Tricot, G. J. K., Mattox, S., Jagannath, S., & Barlogie, B. (1998) · Blood · doi:10.1182/blood.v91.5.1732 · Cited by 216
Extracellular Vesicles – Biomarkers and Effectors of the Cellular Interactome in Cancer
Rak, J. W. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00021 · Cited by 216
Intratumoral Heterogeneity of the Epigenome
Mazor, T., Pankov, A., Song, J. S., & Costello, J. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.009 · Cited by 217
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.
Jakubczak, J. L., Merlino, G. T., French, J. E., Muller, W. J., Paul, B., Adhya, S. L., & Garges, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9073 · Cited by 215
5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement
Widhalm, G., Wolfsberger, S., Minchev, G., Wöehrer, A., Krššák, M., Czech, T., Prayer, D., Asenbaum, S., Hainfellner, J. A., & Knosp, E. (2010) · Cancer · doi:10.1002/cncr.24903 · Cited by 213
Selectively Advantageous Mutations and Hitchhikers in Neoplasms
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3249 · Cited by 220
Collective behavior in cancer cell populations
Deisboeck, T. S., & Couzin, I. D. (2009) · BioEssays · doi:10.1002/bies.200800084 · Cited by 213
Tumour heterogeneity and the evolutionary trade-offs of cancer
Hausser, J., & Alon, U. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0241-6 · Cited by 216
Mutagenic and epigenetic effects of DNA methylation
Gonzalgo, M. L., & Jones, P. A. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(96)00047-6 · Cited by 216
Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue
Galipeau, P. C., Prevo, L. J., Sanchez, C. A., Longton, G., & Reid, B. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2087 · Cited by 213
An analysis of genetic heterogeneity in untreated cancers
Reiter, J. G., Baretti, M., Gerold, J. M., Makohon-Moore, A. P., DAUD, A. I., Iacobuzio–Donahue, C. A., Azad, N. S., Kinzler, K. W., Nowak, M. A., & Vogelstein, B. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0185-x · Cited by 213
Evolutionary foundations for cancer biology
Aktipis, A., & Nesse, R. M. (2013) · Evolutionary Applications · doi:10.1111/eva.12034 · Cited by 207
Current Perspectives in Cancer Immunotherapy
Christofi, T., Baritaki, S., Falzone, L., Libra, M., & Zaravinos, A. (2019) · Cancers · doi:10.3390/cancers11101472 · Cited by 209
Genomic instability and bystander effects: a historical perspective
Little, J. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206988 · Cited by 211
Cytogenetics of human malignant melanoma and premalignant lesions
Balaban, G. B., Herlyn, M., Guerry, D., Bartolo, R. G., Koprowski, H., Clark, W. H., & Nowell̀, P. C. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90024-4 · Cited by 210
Self-citation
Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry.
Barlogie, B., Göhde, W., Johnston, D. A., Smallwood, L., Schumann, J., Drewinko, B., & Freireich, E. J. (1978) · PubMed · Cited by 210
Molecular biology of lung cancer: Clinical implications
Fong, K. M., & Minna, J. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00062-5 · Cited by 211
An Age-Induced Switch to a Hyper-Recombinational State
McMurray, M. A., & Gottschling, D. E. (2003) · Science · doi:10.1126/science.1087706 · Cited by 208
Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature
Inda, M.-D.-M., Bonavia, R., & Seoane, J. (2014) · Cancers · doi:10.3390/cancers6010226 · Cited by 222
High order chromatin architecture shapes the landscape of chromosomal alterations in cancerPreprint
Fudenberg, G., Getz, G. A., Meyerson, M. M., & Mirny, L. A. (2011) · Nature Precedings · doi:10.1038/nbt.2049 · Cited by 206
Tumor heterogeneity and drug resistance.
Dexter, D. L., & Leith, J. T. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.244 · Cited by 208
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Jayachandran, A., Dhungel, B. P., & Steel, J. C. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0307-9 · Cited by 210
Spatial biology of cancer evolution
Seferbekova, Z., Lomakin, A., Yates, L. R., & Gerstung, M. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00553-x · Cited by 227
Untitled work
(2000) · PubMed · Cited by 207
Elimination of oncogenic neighbors by JNK-mediated engulfment in Drosophila
Ohsawa, S., Sugimura, K., Takino, K., Xu, T., Miyawaki, A., & Igaki, T. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.02.007 · Cited by 200
Cancer: Evolution Within a Lifetime
Gerlinger, M., McGranahan, N., Dewhurst, S. M., Burrell, R. A., Tomlinson, I. P. M., & Swanton, C. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092314 · Cited by 210
The detection and implication of genome instability in cancer
Pikor, L. A., Thu, K. L., Vucic, E. A., & Lam, W. L. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9429-5 · Cited by 216
Cell-to-cell fusion as a link between viruses and cancer
Duelli, D. M., & Lazebnik, Y. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2272 · Cited by 209
Cancer cell plasticity: Impact on tumor progression and therapy response
da Silva-Diz, V., Lorenzo-Sanz, L., Bernat‐Peguera, A., Lopez-Cerda, M., & Muñoz, P. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.009 · Cited by 217
Cooperation among cancer cells: applying game theory to cancer
Archetti, M., & Pienta, K. J. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0083-7 · Cited by 203
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Workenhe, S. T., & Mossman, K. L. (2013) · Molecular Therapy · doi:10.1038/mt.2013.220 · Cited by 209
Scalable whole-genome single-cell library preparation without preamplification
Zahn, H., Steif, A., Laks, E., Eirew, P. D., VanInsberghe, M. A., Shah, S. P., Aparicio, S. A. J. R., & Hansen, C. L. (2017) · Nature Methods · doi:10.1038/nmeth.4140 · Cited by 199
The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.
Bronner, M. P., Culin, C., Reed, J. C., & Furth, E. E. (1995) · PubMed Central · Cited by 203
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy
Wiesner, T., Kutzner, H., Cerroni, L., Mihm, M. C., BUSAM, K. J., & Murali, R. (2016) · Pathology · doi:10.1016/j.pathol.2015.12.007 · Cited by 205
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells
Hu, Z., Artibani, M., Alsaadi, A., Wietek, N. C., Morotti, M., Shi, T., Zhong, Z., González, L. S., El-Sahhar, S., Carrami, E. M., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.003 · Cited by 195
The challenge of targeting cancer stem cells to halt metastasis
Agliano, A., Calvo, A., & Box, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.003 · Cited by 201
Metapopulation dynamics and spatial heterogeneity in cancer
González-Garcı́a, I., Solé, R. V., & Costa, J. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202139299 · Cited by 201
A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.
Kraus, M. H., Yuasa, Y., & Aaronson, S. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5384 · Cited by 197
Therapeutic targeting of tumor suppressor genes
Morris, L. G. T., & Chan, T. A.-T. (2014) · Cancer · doi:10.1002/cncr.29140 · Cited by 209
Patterns of Stem Cell Divisions Contribute to Plant Longevity
Burian, A., de Reuille, P. B., & Kuhlemeier, C. J. (2016) · Current Biology · doi:10.1016/j.cub.2016.03.067 · Cited by 201
Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer
Schwab, M., & Amler, L. C. (1990) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870010302 · Cited by 200
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies
Hafner, C. M., Knuechel, R., Stoehr, R., & Hartmann, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10544 · Cited by 199
Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma.
Burmer, G. C., & Loeb, L. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2403 · Cited by 197
The prognostic significance of cytogenetics and molecular profiling in multiple myeloma
Sawyer, J. R. (2011) · Cancer Genetics · doi:10.1016/j.cancergencyto.2010.11.002 · Cited by 198
Clonal evolution of colorectal cancer in IBD
Choi, C.-H. R., Bakir, I. A., Hart, A. L., & Graham, T. A. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.1 · Cited by 202
Molecular aspects of the metastatic cascade
Hart, I. R., Goode, N. T., & Wilson, R. E. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90035-8 · Cited by 197
Differential DNA repair in transcriptionally active and inactive proto-oncogenes: c-abl and c-mos
Madhani, H. D., Bohr, V. A., & Hanawalt, P. C. (1986) · Cell · doi:10.1016/0092-8674(86)90327-2 · Cited by 195
Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity
Sottoriva, A., Verhoeff, J. J. C., Borovski, T., McWeeney, S. K., Александрович, Н. Л., Medema, J. P., Sloot, P. M. A., & Vermeulen, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3663 · Cited by 200
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
Tellez-Gabriel, M., Ory, B., Lamoureux, F., Heymann, M., & Heymann, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122142 · Cited by 203
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
El-Sayes, N., Vito, A., & Mossman, K. L. (2021) · Cancers · doi:10.3390/cancers13040806 · Cited by 208
p53 mutation and protein accumulation during multistage human esophageal carcinogenesis.
Bennett, W. P., Hollstein, M. C., Metcalf, R. A., Welsh, J. A., He, A., Zhu, S., Kusters, I., Resau, J. H., Trump, B. F., & Lane, D. P. (1992) · PubMed · Cited by 196
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+ · Cited by 621
Cancer selection
Leroi, A. M., Koufopanou, V., & Burt, A. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1016 · Cited by 202
Technical considerations for studying cancer metastasis in vivo
Welch, D. R. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018477516367 · Cited by 192
Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors.
Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold‐Mende, C. C., Schuhmann, A., & Bosch, F. X. (1993) · PubMed · Cited by 195
Interaction with surrounding normal epithelial cells influences signalling pathways and behaviour of Src-transformed cells
Kajita, M., Hogan, C., Harris, A. R., Dupré‐Crochet, S., Itasaki, N., Kawakami, K., Charras, G., Tada, M., & Fujita, Y. (2009) · Journal of Cell Science · doi:10.1242/jcs.057976 · Cited by 194
Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells
Borel, F., Lohez, O. D., Lacroix, F., & Margolis, R. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152205299 · Cited by 196
The Combination of Genetic Instability and Clonal Expansion Predicts Progression to Esophageal Adenocarcinoma
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., & Reid, B. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1738 · Cited by 194
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity
Morales, C., Biran, A., Burney, M. J., Patel, H., Henser‐Brownhill, T., Cohen, A.-H., Li, Y., Ben‐Hamo, R., Nye, E. L., Spencer‐Dene, B., et al. (2016) · Science · doi:10.1126/science.aaf1644 · Cited by 193
Targeted Cancer Therapies in the Twenty-First Century: Lessons From Imatinib
Stegmeier, F. P., Warmuth, M., Sellers, W. R., & Dorsch, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.297 · Cited by 196
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J. I. G., & Harding, A. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 197
Differentiation patterns in the blastic phase of chronic myeloid leukemia.
Griffin, J. D., Todd, R. F., Ritz, J., Nadler, L. M., Canellos, G. P., Rosenthal, D. I., Gallivan, M. V. E., Beveridge, R. P., Weinstein, H. J., Karp, D. D., et al. (1983) · PubMed · Cited by 192
Characterization of the Intestinal Cancer Stem Cell Marker CD166 in the Human and Mouse Gastrointestinal Tract
Levin, T. G., Powell, A. E., Davies, P. S., Silk, A. D., Dismuke, A. D., Anderson, E. C., Swain, J. R., & Wong, M. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.053 · Cited by 197
Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
Książkiewicz, M., Markiewicz, A., & Zaczek, A. J. (2012) · Pathobiology · doi:10.1159/000337106 · Cited by 192
High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma
Yang, B., Feng, X., Liu, H., Tong, R., Wu, J., Li, C., Yu, H., Chen, Y., Cheng, Q., Chen, J., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01450-5 · Cited by 190
Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin
Forrest, S., Ng, K. W., Findlay, D. M., Michelangeli, V. P., Livesey, S. A., Partridge, N. C., Zajac, J. D., & Martin, T. J. (1985) · Calcified Tissue International · doi:10.1007/bf02557679 · Cited by 188
Generation of a strong mutator phenotype in yeast by imbalanced base excision repair
Glassner, B. J., Rasmussen, L. J., Najarian, M. T., Posnick, L. M., & Samson, L. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9997 · Cited by 189
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Pines, G., Köstler, W. J., & Yarden, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.019 · Cited by 199
Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response
Marriott, S. J., & Semmes, O. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208976 · Cited by 188
Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self
Fidler, I. J., & Schroit, A. J. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90009-1 · Cited by 188

Authors: Nowell, P. C.
Affiliations: School of Medicine, University of Pennsylvania, Philadelphia 19174.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1976-10
Volume: 194
Issue: 4260
Pages: 23-28
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.959840
OpenAlex: W1967304777
Cited by: 6,471
References: 52
Citations by year: 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
FWCI: 16.73
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
MeSH terms: Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks